New shot in the eye aims to halt diabetic vision loss
NCT ID NCT07228559
Summary
This is an early safety study testing a single experimental injection (avoralstat) into the eye for people with diabetic macular edema (DME), a cause of vision loss. The main goal is to see if the injection is safe and tolerable. Researchers will also look for early signs that it might reduce swelling and improve vision in the 9 participants over 24 weeks.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA (DME) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigative Site 1
RECRUITINGSydney, New South Wales, Australia
-
Investigative Site 2
RECRUITINGSydney, New South Wales, Australia
-
Investigative Site 3
RECRUITINGSydney, New South Wales, Australia
-
Investigative Site 4
RECRUITINGAdelaide, South Australia, Australia
-
Investigative Site 5
RECRUITINGMelbourne, Victoria, Australia
-
Investigative Site 6
RECRUITINGSacramento, California, 95825, United States
-
Investigative Site 7
RECRUITINGKaty, Texas, 77494, United States
-
Investigative Site 8
RECRUITINGThe Woodlands, Texas, 77384, United States
Conditions
Explore the condition pages connected to this study.